Ethics and Drug Resistance: Collective Responsibility for Global Public Health
dc.contributor.editor | Jamrozik, Euzebiusz | |
dc.contributor.editor | Selgelid, Michael | |
dc.date.accessioned | 2020-11-13T13:34:54Z | |
dc.date.available | 2020-11-13T13:34:54Z | |
dc.date.issued | 2020 | |
dc.identifier | ONIX_20201113_9783030278748_19 | |
dc.identifier.uri | https://library.oapen.org/handle/20.500.12657/42913 | |
dc.description.abstract | This Open Access volume provides in-depth analysis of the wide range of ethical issues associated with drug-resistant infectious diseases. Antimicrobial resistance (AMR) is widely recognized to be one of the greatest threats to global public health in coming decades; and it has thus become a major topic of discussion among leading bioethicists and scholars from related disciplines including economics, epidemiology, law, and political theory. Topics covered in this volume include responsible use of antimicrobials; control of multi-resistant hospital-acquired infections; privacy and data collection; antibiotic use in childhood and at the end of life; agricultural and veterinary sources of resistance; resistant HIV, tuberculosis, and malaria; mandatory treatment; and trade-offs between current and future generations. As the first book focused on ethical issues associated with drug resistance, it makes a timely contribution to debates regarding practice and policy that are of crucial importance to global public health in the 21st century. | |
dc.language | English | |
dc.relation.ispartofseries | Public Health Ethics Analysis | |
dc.subject.classification | thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSA Life sciences: general issues::PSAD Bioethics | en_US |
dc.subject.classification | thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology | en_US |
dc.subject.classification | thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCJ Infectious and contagious diseases | en_US |
dc.subject.other | Bioethics | |
dc.subject.other | Drug Resistance | |
dc.subject.other | Infectious Diseases | |
dc.subject.other | Moral Philosophy and Applied Ethics | |
dc.subject.other | Medical Microbiology | |
dc.subject.other | Internal Medicine | |
dc.subject.other | antimicrobial resistance | |
dc.subject.other | public health ethics | |
dc.subject.other | collective responsibility | |
dc.subject.other | infectious disease | |
dc.subject.other | global health | |
dc.subject.other | hospital acquired infection | |
dc.subject.other | animal ethics | |
dc.subject.other | animal epidemiology | |
dc.subject.other | TB resistance and human rights | |
dc.subject.other | TB resistance in developing countries | |
dc.subject.other | privacy and data collection | |
dc.subject.other | ethics and AMR regulation | |
dc.subject.other | ethics of drug development | |
dc.subject.other | Pharmacology | |
dc.subject.other | Infectious & contagious diseases | |
dc.title | Ethics and Drug Resistance: Collective Responsibility for Global Public Health | |
dc.type | book | |
oapen.identifier.doi | 10.1007/978-3-030-27874-8 | |
oapen.relation.isPublishedBy | 6c6992af-b843-4f46-859c-f6e9998e40d5 | |
oapen.relation.hasChapter | f96e3a09-3384-4f85-9c65-3498b0482115 | |
oapen.imprint | Springer International Publishing | |
oapen.series.number | 5 | |
oapen.pages | 448 |